Financial Gravity Asset Management’s Opus Genetics IRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-16,555
Closed -$15.6K – 1112
2025
Q2
$15.6K Hold
16,555
– – ﹤0.01% 499
2025
Q1
$16.3K Hold
16,555
– – ﹤0.01% 515
2024
Q4
$19.7K Buy
+16,555
New +$19K ﹤0.01% 447

Other funds holding IRD

Financial Gravity Asset Management's IRD Position: Q3 2025 in Review

Financial Gravity Asset Management sold out of Opus Genetics (IRD) in Q3 2025, closing a stake of 16,555 shares — an estimated $15.6K sold.

Financial Gravity Asset Management first reported a position in IRD in Q4 2024 and held it in 3 quarters. The position peaked at $19.7K in Q4 2024. 48 funds tracked by Wall St. Rank hold IRD as of Q3 2025.

  • Financial Gravity Asset Management reported no remaining Opus Genetics position as of Q3 2025 after selling out during the quarter.
  • Financial Gravity Asset Management sold 16,555 Opus Genetics shares in Q3 2025, an estimated $15.6K.
  • Financial Gravity Asset Management first reported a position in Opus Genetics in Q4 2024 and held it in 3 quarters.
  • Financial Gravity Asset Management's Opus Genetics position peaked at $19.7K in Q4 2024.
  • 48 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2025.

Based on Financial Gravity Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.